Physician

David Scott Deuser, M.D.

According to 2025 Medicare claims, David Deuser, M.D. (NPI: 1427237015) practices psychiatry in the Brunswick-St. Simons, GA market, with the plurality of this provider's patient population coming from Glynn, GA. This provider's primary affiliated billing organization is PRIVIA MEDICAL GROUP OF GEORGIA LLC (NPI: 1013313857; TIN: 202265068) and primary practice location at 31525-7921. Deuser is affiliated with the Privia Quality Network of Georgia (ACO ID: A3236), participating under the MSSP model.

Deuser's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 187 traditional Medicare patients, billed 2,726 HCPCS/CPT codes, and received $87,743 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 3,556 prescription claims across 194 beneficiaries totaling $512,524 in drug costs, led by Vraylar (Cariprazine Hcl). Open Payments data shows 160 records totaling $2,830. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $12,944 to $87,743. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $375,122 and ending at $512,524. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	132	307	$12,944
2016	129	326	$15,090
2017	167	402	$20,865
2018	144	388	$19,192
2019	112	308	$20,161
2020	113	444	$27,072
2021	90	285	$19,952
2022	78	627	$15,148
2023	164	2,692	$68,921
2024	187	2,726	$87,743

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	192	3,652	$375,122
2016	193	3,988	$344,089
2017	232	4,814	$485,571
2018	236	5,202	$581,869
2019	240	2,753	$269,437
2020	209	3,008	$310,443
2021	188	3,451	$360,534
2022	223	3,755	$505,942
2023	206	4,082	$644,146
2024	194	3,556	$512,524

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	24	24	$117
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	160	563	$81
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	31	69	$61
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	170	622	$11
96127	Assessment of emotional or behavioral problems	154	1,080	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Vraylar	Cariprazine Hcl	94	3,144	$152,245
Lybalvi	Olanzapine/Samidorphan Malate	13	500	$36,880
Abilify Maintena	Aripiprazole	12	330	$34,737
Invega Sustenna	Paliperidone Palmitate	14	329	$33,188
Trintellix	Vortioxetine Hydrobromide	38	1,380	$26,673

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	160	$2,830	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David Scott Deuser, M.D.?

Tedicare shows public-source Medicare data for David Scott Deuser, M.D. (NPI 1427237015), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Scott Deuser, M.D. have ACO affiliation data?

David Scott Deuser, M.D. is shown with ACO affiliation data for Privia Quality Network of Georgia (MSSP, ACO ID A3236).

What billing organization is linked to David Scott Deuser, M.D.?

David Scott Deuser, M.D. is linked to PRIVIA MEDICAL GROUP OF GEORGIA LLC (billing NPI 1013313857) in the available physician profile data.

Does David Scott Deuser, M.D. have Open Payments data?

David Scott Deuser, M.D. has 160 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.